Studies have shown that active fund managers routinely underperform the S&P500 index*​

Avanos Medical, Inc. (NYSE: AVNS)

AVNS Stock Predictions and Ratings

WSX Rating:
SELL
WSX Forecast (1yr):
-0.40%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE

AVNS Stock Analysis

AVNS PE Ratio:

AVNS PEG Ratio:

AVNS Forward EPS Growth (12 month): 25.00%

AVNS PS Ratio: 1.6

AVNS PSG Ratio: 0.4

AVNS Forward Revenue Growth (12 month): 4.20%

AVNS Articles

No data was found